Fiduciary Management Associates’s Ligand Pharmaceuticals LGND Stock Holding History

Fiduciary Management Associates’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$17.2M	Sell	257,628 -537	-0.2%	-$32.6K	1.13%	60
2015 Q4	$17.5M	Sell	258,165 -25,972	-9%	-$1.6M	1.02%	70
2015 Q3	$15.2M	Sell	284,137 -56,441	-17%	-$3.42M	0.99%	68
2015 Q2	$21.4M	Sell	340,578 -183,739	-35%	-$10M	1.26%	44
2015 Q1	$25.2M	Buy	524,317 +53,340	+11%	+$2.04M	1.51%	11
2014 Q4	$15.6M	Buy	+470,977	New	+$15.3M	0.97%	71

Other funds holding LGND

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Fiduciary Management Associates's LGND Position: Q1 2016 in Review

Fiduciary Management Associates reduced its Ligand Pharmaceuticals (LGND) stake by 0.21% in Q1 2016, selling an estimated $32.6K and leaving 257,628 shares worth $17.2M. The position accounts for 1.13% of the portfolio, ranked #60.

Fiduciary Management Associates first reported a position in LGND in Q4 2014 and has held it in 6 quarters since. The position peaked at $25.2M in Q1 2015. 251 funds tracked by Wall St. Rank hold LGND as of Q1 2016.

Fiduciary Management Associates held 257,628 shares of Ligand Pharmaceuticals worth $17.2M as of Q1 2016.
Fiduciary Management Associates sold 537 Ligand Pharmaceuticals shares in Q1 2016, an estimated $32.6K.
Ligand Pharmaceuticals made up 1.13% of Fiduciary Management Associates's portfolio in Q1 2016, its #60 holding.
Fiduciary Management Associates first reported a position in Ligand Pharmaceuticals in Q4 2014 and has held it in 6 quarters since.
Fiduciary Management Associates's Ligand Pharmaceuticals position peaked at $25.2M in Q1 2015.
251 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2016.

Based on Fiduciary Management Associates's 13F filing for Q1 2016, filed 4 May 2016.